Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1059-1065

  Krone, Nils ^a   Braun, Andreas ^a   Roscher, Adelbert Anton ^a   Knorr, Dietrich ^a   Schwarz, Hans Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; HYDROXYPROGESTERONE; MINERALOCORTICOID; PRASTERONE SULFATE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ALLELE; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DELETION; GENOTYPE; GERMANY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; SALT LOSING NEPHRITIS; VIRILIZATION;

EID: 0034452971     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.3.6441     Document Type: Article

References (33)

1. Mutations in steroid 21-hydroxylase (CYP21)
2. High frequency of nonclassical steroid 21-hydroxylase deficiency
3. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man
4. Structure of human steroid 21-hydroxylase genes
5. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene
6. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
7. Evidence for frequent gene conversion in the steroid 21-hydroxylase P- 450(C21) gene: Implications for steroid 21-hydroxylase deficiency
8. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): Implications for diagnosis, prognosis and treatment
9. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency
10. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia
11. Novel nonsense mutation (W302X) in the steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting form of congenital adrenal hyperplasia
12. Steroid 21-hydroxylase deficiency: Three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations
13. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
14. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
15. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype
16. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population
17. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population
18. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
19. 17-Hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia
20. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene
21. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency
22. Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency
23. Uniparental disomy for chromosome 6 results in steroid 21-hydroxylase deficiency: Evidence of different genetic mechanisms involved in the production of the disease
24. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations
25. The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction
26. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
27. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
28. Study of a kindred with classic congenital adrenal hyperplasia: Diagnostic challenge due to phenotypic variance
29. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase
30. Multiple regulatory elements determine adrenocortical expression of steroid 21-hydroxylase
31. The human complement C4B/steroid 21-hydroxylase (CYP21) and complement C4A/21-hydroxylase pseudogene (CYP21P) intergenic sequences: Comparison and identification of possible regulatory elements
32. A novel frameshift mutation (141delT) in exon 1 of the 21-hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia. Mutation in brief no. 255. Online